{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:56:09Z","timestamp":1781232969319,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003653","name":"Korea National Institute of Health","doi-asserted-by":"publisher","award":["2022E200100"],"award-info":[{"award-number":["2022E200100"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chonnam National University Hospital Biomedical Research Institute","award":["BCRI24033"],"award-info":[{"award-number":["BCRI24033"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13388-2","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T02:34:56Z","timestamp":1777257296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors associated with extended treatment duration in patients with drug-susceptible pulmonary tuberculosis: a prospective multicentre cohort study in South Korea"],"prefix":"10.1186","volume":"26","author":[{"given":"Chang-Seok","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Ok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Joon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Sang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eung Gu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Soo","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee Youn","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heayon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seunghoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Hyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonhee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwon","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Jung","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Jeong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon-Kyoung","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganghee","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Young","family":"Kyung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsoo","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Soo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"13388_CR1","unstructured":"World Health Organization. Global tuberculosis report. 2024. Geneva, Switzerland: WHO, 2024."},{"issue":"9332","key":"13388_CR2","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S0140-6736(02)09742-8","volume":"360","author":"D Benator","year":"2002","unstructured":"Benator D, Bhattacharya M, Bozeman L, Burman W, Cantazaro A, Chaisson R, Gordin F, Horsburgh CR, Horton J, Khan A, et al. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. Lancet. 2002;360(9332):528\u201334.","journal-title":"Lancet"},{"issue":"10","key":"13388_CR3","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1164\/rccm.200407-905OC","volume":"170","author":"KC Chang","year":"2004","unstructured":"Chang KC, Leung CC, Yew WW, Ho SC, Tam CM. A nested case-control study on treatment-related risk factors for early relapse of tuberculosis. Am J Respir Crit Care Med. 2004;170(10):1124\u201330.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"13388_CR4","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1164\/rccm.200511-1834OC","volume":"174","author":"A Khan","year":"2006","unstructured":"Khan A, Sterling TR, Reves R, Vernon A, Horsburgh CR. Lack of weight gain and relapse risk in a large tuberculosis treatment trial. Am J Respir Crit Care Med. 2006;174(3):344\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"13388_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1741-7015-9-81","volume":"9","author":"MA Baker","year":"2011","unstructured":"Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lonnroth K, Ottmani SE, Goonesekera SD, Murray MB. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011;9:81.","journal-title":"BMC Med"},{"issue":"4","key":"13388_CR6","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.rmed.2014.01.010","volume":"108","author":"KW Jo","year":"2014","unstructured":"Jo KW, Yoo JW, Hong Y, Lee JS, Lee SD, Kim WS, Kim DS, Shim TS. Risk factors for 1-year relapse of pulmonary tuberculosis treated with a 6-month daily regimen. Respir Med. 2014;108(4):654\u20139.","journal-title":"Respir Med"},{"issue":"2","key":"13388_CR7","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1378\/chest.14-0918","volume":"147","author":"JY Wang","year":"2015","unstructured":"Wang JY, Lee MC, Shu CC, Lee CH, Lee LN, Chao KM, Chang FY. Optimal duration of anti-TB treatment in patients with diabetes: nine or six months? Chest. 2015;147(2):520\u20138.","journal-title":"Chest"},{"issue":"7","key":"13388_CR8","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1093\/cid\/ciw376","volume":"63","author":"P Nahid","year":"2016","unstructured":"Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, et al. Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016;63(7):e147\u201395.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"13388_CR9","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/j.jiph.2023.09.005","volume":"16","author":"CS Lee","year":"2023","unstructured":"Lee CS, Ho CH, Liao KM, Wu YC, Shu CC. The incidence of tuberculosis recurrence: Impacts of treatment duration of and adherence to standard anti-tuberculous therapy. J Infect Public Health. 2023;16(11):1778\u201383.","journal-title":"J Infect Public Health"},{"key":"13388_CR10","doi-asserted-by":"crossref","unstructured":"Walker EF, Flook M, Rodger AJ, Fielding KL, Stagg HR. Quantifying non-adherence to anti-tuberculosis treatment due to early discontinuation: a systematic literature review of timings to loss to follow-up. BMJ Open Respir Res 2024, 11(1).","DOI":"10.1136\/bmjresp-2023-001894"},{"key":"13388_CR11","doi-asserted-by":"publisher","first-page":"e2018036","DOI":"10.4178\/epih.e2018036","volume":"40","author":"KS Cho","year":"2018","unstructured":"Cho KS. Tuberculosis control in the Republic of Korea. Epidemiol Health. 2018;40:e2018036.","journal-title":"Epidemiol Health"},{"key":"13388_CR12","unstructured":"Development OfEC-oa. OECD Reviews of Public Health: Korea. In: OECD Publishing. 2020."},{"issue":"7","key":"13388_CR13","doi-asserted-by":"publisher","first-page":"e1003717","DOI":"10.1371\/journal.pmed.1003717","volume":"18","author":"S Yu","year":"2021","unstructured":"Yu S, Sohn H, Kim HY, Kim H, Oh KH, Kim HJ, Chung H, Choi H. Evaluating the impact of the nationwide public-private mix (PPM) program for tuberculosis under National Health Insurance in South Korea: A difference in differences analysis. PLoS Med. 2021;18(7):e1003717.","journal-title":"PLoS Med"},{"issue":"1","key":"13388_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4046\/trd.2022.0111","volume":"86","author":"J Min","year":"2023","unstructured":"Min J, Kim HW, Kim JS. Tuberculosis: Republic of Korea, 2021. Tuberc Respir Dis (Seoul). 2023;86(1):67\u20139.","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"10","key":"13388_CR15","doi-asserted-by":"publisher","first-page":"e021235","DOI":"10.1136\/bmjopen-2017-021235","volume":"8","author":"J Min","year":"2018","unstructured":"Min J, Chung C, Lim J, Park JH, Shin KS, Jung SS, Lee KM. Cohort Study of Pulmonary Tuberculosis (COSMOTB) identifying drug-resistant mutations: protocol for a prospective observational study in Korea. BMJ Open. 2018;8(10):e021235.","journal-title":"BMJ Open"},{"issue":"11","key":"13388_CR16","doi-asserted-by":"publisher","first-page":"e0166030","DOI":"10.1371\/journal.pone.0166030","volume":"11","author":"N Van\u2019t Boveneind-Vrubleuskaya","year":"2016","unstructured":"Van\u2019t Boveneind-Vrubleuskaya N, Daskapan A, Kosterink JG, van der Werf TS, van den Hof S, Alffenaar JC. Predictors of Prolonged TB Treatment in a Dutch Outpatient Setting. PLoS ONE. 2016;11(11):e0166030.","journal-title":"PLoS ONE"},{"issue":"2","key":"13388_CR17","doi-asserted-by":"publisher","first-page":"e0281097","DOI":"10.1371\/journal.pone.0281097","volume":"18","author":"E Pietersen","year":"2023","unstructured":"Pietersen E, Anderson K, Cox H, Dheda K, Bian A, Shepherd BE, Sterling TR, Warren RM, van der Heijden YF. Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa. PLoS ONE. 2023;18(2):e0281097.","journal-title":"PLoS ONE"},{"issue":"7","key":"13388_CR18","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/resp.14714","volume":"29","author":"KH Kim","year":"2024","unstructured":"Kim KH, Kim HW, Kim YH, Park Y, Jung SS, Kim JW, Oh JY, Lee H, Kim SK, Kim SH, et al. Effect of complicated, untreated and uncontrolled diabetes and pre-diabetes on treatment outcome among patients with pulmonary tuberculosis. Respirology. 2024;29(7):624\u201332.","journal-title":"Respirology"},{"issue":"9","key":"13388_CR19","doi-asserted-by":"publisher","first-page":"e0309902","DOI":"10.1371\/journal.pone.0309902","volume":"19","author":"JY Yoon","year":"2024","unstructured":"Yoon JY, Kim TO, Kim JS, Kim HW, Lee EG, Jung SS, Oh JY, Kim JW, Lee SH, Kim S, et al. Impact of pyrazinamide usage on serious adverse events in elderly tuberculosis patients: A multicenter cohort study. PLoS ONE. 2024;19(9):e0309902.","journal-title":"PLoS ONE"},{"issue":"8","key":"13388_CR20","doi-asserted-by":"publisher","first-page":"e71116","DOI":"10.1371\/journal.pone.0071116","volume":"8","author":"RS Wallis","year":"2013","unstructured":"Wallis RS, Wang C, Meyer D, Thomas N. Month 2 Culture Status and Treatment Duration as Predictors of Tuberculosis Relapse Risk in a Meta-Regression Model. PLoS ONE. 2013;8(8):e71116.","journal-title":"PLoS ONE"},{"issue":"6","key":"13388_CR21","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1016\/S1473-3099(20)30148-1","volume":"20","author":"ME Urbanowski","year":"2020","unstructured":"Urbanowski ME, Ordonez AA, Ruiz-Bedoya CA, Jain SK, Bishai WR. Cavitary tuberculosis: the gateway of disease transmission. Lancet Infect Dis. 2020;20(6):e117\u201328.","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"13388_CR22","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.5588\/ijtld.12.0113","volume":"16","author":"J Lee","year":"2012","unstructured":"Lee J, Lee BJ, Yoon HI, Lee CT, Lee JH. Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion. Int J Tuberc Lung Dis. 2012;16(10):1344\u20138.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"13388_CR23","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/1471-2334-14-360","volume":"14","author":"H Choi","year":"2014","unstructured":"Choi H, Lee M, Chen RY, Kim Y, Yoon S, Joh JS, Park SK, Dodd LE, Lee J, Song T, et al. Predictors of pulmonary tuberculosis treatment outcomes in South Korea: a prospective cohort study, 2005\u20132012. BMC Infect Dis. 2014;14(1):360.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"13388_CR24","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/01.mjt.0000183719.84390.4d","volume":"14","author":"ES ElDesoky","year":"2007","unstructured":"ElDesoky ES. Pharmacokinetic-pharmacodynamic crisis in the elderly. Am J Ther. 2007;14(5):488\u201398.","journal-title":"Am J Ther"},{"issue":"2","key":"13388_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1124\/pr.56.2.4","volume":"56","author":"AJ McLean","year":"2004","unstructured":"McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev. 2004;56(2):163\u201384.","journal-title":"Pharmacol Rev"},{"issue":"3","key":"13388_CR26","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1530\/JOE-15-0170","volume":"226","author":"MC Mendes","year":"2015","unstructured":"Mendes MC, Pimentel GD, Costa FO, Carvalheira JB. Molecular and neuroendocrine mechanisms of cancer cachexia. J Endocrinol. 2015;226(3):R29\u201343.","journal-title":"J Endocrinol"},{"issue":"10","key":"13388_CR27","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1164\/rccm.200801-132OC","volume":"178","author":"DH Kim","year":"2008","unstructured":"Kim DH, Kim HJ, Park SK, Kong SJ, Kim YS, Kim TH, Kim EK, Lee KM, Lee SS, Park JS, et al. Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis. Am J Respir Crit Care Med. 2008;178(10):1075\u201382.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"13388_CR28","doi-asserted-by":"publisher","first-page":"e0268290","DOI":"10.1371\/journal.pone.0268290","volume":"17","author":"HM Youn","year":"2022","unstructured":"Youn HM, Shin M-K, Jeong D, Kim H-J, Choi H, Kang YA. Risk factors associated with tuberculosis recurrence in South Korea determined using a nationwide cohort study. PLoS ONE. 2022;17(6):e0268290.","journal-title":"PLoS ONE"},{"issue":"7","key":"13388_CR29","doi-asserted-by":"publisher","first-page":"906","DOI":"10.5588\/ijtld.10.0448","volume":"15","author":"AC Pettit","year":"2011","unstructured":"Pettit AC, Kaltenbach LA, Maruri F, Cummins J, Smith TR, Warkentin JV, Griffin MR, Sterling TR. Chronic lung disease and HIV infection are risk factors for recurrent tuberculosis in a low-incidence setting. Int J Tuberc Lung Dis. 2011;15(7):906\u201311.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"13388_CR30","doi-asserted-by":"publisher","first-page":"e10138","DOI":"10.1371\/journal.pone.0010138","volume":"5","author":"M Inghammar","year":"2010","unstructured":"Inghammar M, Ekbom A, Engstr\u00f6m G, Ljungberg B, Romanus V, L\u00f6fdahl CG, Egesten A. COPD and the risk of tuberculosis\u2013a population-based cohort study. PLoS ONE. 2010;5(4):e10138.","journal-title":"PLoS ONE"},{"issue":"2","key":"13388_CR31","doi-asserted-by":"publisher","first-page":"1700157","DOI":"10.1183\/13993003.00157-2017","volume":"50","author":"CC Dobler","year":"2017","unstructured":"Dobler CC, Cheung K, Nguyen J, Martin A. Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis. Eur Respir J. 2017;50(2):1700157.","journal-title":"Eur Respir J"},{"issue":"2","key":"13388_CR32","doi-asserted-by":"publisher","first-page":"2200930","DOI":"10.1183\/13993003.00930-2022","volume":"60","author":"C Chung","year":"2022","unstructured":"Chung C, Shin JE, Jeon D, Kang H, Yim J-J, Jo K-W, Shim TS. Treatment outcomes of multidrug-resistant tuberculosis with chronic kidney\/liver disease. Eur Respir J. 2022;60(2):2200930.","journal-title":"Eur Respir J"},{"issue":"3","key":"13388_CR33","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/eji.201344301","volume":"44","author":"N Martinez","year":"2014","unstructured":"Martinez N, Kornfeld H. Diabetes and immunity to tuberculosis. Eur J Immunol. 2014;44(3):617\u201326.","journal-title":"Eur J Immunol"},{"issue":"7","key":"13388_CR34","doi-asserted-by":"publisher","first-page":"783","DOI":"10.5588\/ijtld.18.0433","volume":"23","author":"P Huangfu","year":"2019","unstructured":"Huangfu P, Ugarte-Gil C, Golub J, Pearson F, Critchley J. The effects of diabetes on tuberculosis treatment outcomes: an updated systematic review and meta-analysis. Int J Tuberc Lung Dis. 2019;23(7):783\u201396.","journal-title":"Int J Tuberc Lung Dis"},{"key":"13388_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1741-7015-9-81","volume":"9","author":"MA Baker","year":"2011","unstructured":"Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, L\u00f6nnroth K, Ottmani SE, Goonesekera SD, Murray MB. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011;9:81.","journal-title":"BMC Med"},{"issue":"1","key":"13388_CR36","doi-asserted-by":"publisher","first-page":"2313683","DOI":"10.1080\/07853890.2024.2313683","volume":"56","author":"M Khattak","year":"2024","unstructured":"Khattak M, Rehman AU, Muqaddas T, Hussain R, Rasool MF, Saleem Z, Almalki MS, Alturkistani SA, Firash SZ, Alzahrani OM, et al. Tuberculosis (TB) treatment challenges in TB-diabetes comorbid patients: a systematic review and meta-analysis. Ann Med. 2024;56(1):2313683.","journal-title":"Ann Med"},{"issue":"3","key":"13388_CR37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1378\/chest.36.3.293","volume":"36","author":"W Mandel","year":"1959","unstructured":"Mandel W. Pyridoxine and the Isoniazid-Induced Neuropathy. Dis Chest. 1959;36(3):293\u20136.","journal-title":"Dis Chest"},{"issue":"3","key":"13388_CR38","doi-asserted-by":"publisher","first-page":"352","DOI":"10.5588\/ijtld.13.0726","volume":"18","author":"P Baghaei","year":"2014","unstructured":"Baghaei P, Marjani M, Tabarsi P, Moniri A, Rashidfarrokhi F, Ahmadi F, Nassiri AA, Masjedi MR, Velayati AA, Cattamanchi A. Impact of chronic renal failure on anti-tuberculosis treatment outcomes. Int J Tuberc Lung Dis. 2014;18(3):352\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"13388_CR39","first-page":"2234","volume":"7","author":"FS Lin","year":"2015","unstructured":"Lin FS, Wu MY, Tu WJ, Pan HQ, Zheng J, Shi JW, Fei ZT, Zhang RM, Yan WG, Shang MQ, et al. A cross-sectional and follow-up study of leukopenia in tuberculosis patients: prevalence, risk factors and impact of anti-tuberculosis treatment. J Thorac Dis. 2015;7(12):2234\u201342.","journal-title":"J Thorac Dis"},{"key":"13388_CR40","doi-asserted-by":"crossref","unstructured":"Chung SJ, Byeon S-j, Choi J-H. Analysis of adverse drug reactions to first-line anti-tuberculosis drugs using the Korea adverse event reporting system. J Korean Med Sci. 2022;37(16).","DOI":"10.3346\/jkms.2022.37.e128"},{"issue":"2","key":"13388_CR41","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1183\/09031936.00007410","volume":"37","author":"W-J Su","year":"2010","unstructured":"Su W-J, Feng J-Y, Chiu Y-C, Huang S-F, Lee Y-C. Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis. Eur Respir J. 2010;37(2):376\u201383.","journal-title":"Eur Respir J"},{"issue":"8","key":"13388_CR42","doi-asserted-by":"publisher","first-page":"e103768","DOI":"10.1371\/journal.pone.0103768","volume":"9","author":"HY Lee","year":"2014","unstructured":"Lee HY, Chae KO, Lee CH, Choi SM, Lee J, Park YS, Lee SM, Yoo CG, Kim YW, Han SK, et al. Culture conversion rate at 2 months of treatment according to diagnostic methods among patients with culture-positive pulmonary tuberculosis. PLoS ONE. 2014;9(8):e103768.","journal-title":"PLoS ONE"},{"key":"13388_CR43","unstructured":"Joint Committee for the Development of Korean Guidelines for Tuberculosis. Korea Centers for Disease Control and Prevention. Korean guidelines for tuberculosis. 5th ed. Seoul and Cheongwon: Joint Committee for the Development of Korean Guidelines for Tuberculosis, Korea Centers for Disease Control and Prevention; 2024."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13388-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13388-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13388-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T01:56:53Z","timestamp":1781229413000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13388-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13388"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13388-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"20 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Boards and Ethics Committees of all participating institutions, including Chonnam National University Hospital (IRB No. CNUH-2022-122). Written informed consent was obtained from all adult participants before their enrolment in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1123"}}